-
CJ Bioscience anchors clinical strategy around microbiome drug pipeline
19 Jun 2025 03:20 GMT
… , which is why Korean microbiome drug development companies often have difficulty in contract …
-
Satellos Bioscience Shareholders Elect Two New Board Members
18 Jun 2025 21:11 GMT
… .
Satellos is a clinical-stage drug development company focused on restoring natural muscle …
-
Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders
18 Jun 2025 21:11 GMT
… .
Satellos is a clinical-stage drug development company focused on restoring natural muscle …
-
BIO 2025: New Perspectives on RNA Editing
18 Jun 2025 16:28 GMT
… not like, our grandparents' drug development companies. You don't, you …
-
AI robotic drug development company Persist AI raises $12 million
22 May 2025 03:46 GMT
-
Drug development company lands £1.1m boost marking “significant milestone”
11 Apr 2025 11:11 GMT
A Newcastle-based drug development company has secured a £1.1m …
-
AI Drug Development Company Receives $600M in First Round Financing
02 Apr 2025 16:10 GMT
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital from existing …
-
[Reporter's Notebook] China surges ahead in oncology R&D, leaving Korea struggling to keep pace
17 Jun 2025 06:23 GMT
… because the strategies of Korean drug development companies have been largely invisible, … Ints Bio, finding any drug development companies that shared clinical results even … report card for Korean drug development companies focused on developing anticancer …
-
EXCL: DHSC-owned drug development company to close
06 Mar 2025 23:46 GMT
Porton Biopharma, a drug development and production company owned by the Department of Health and Social Care, will be shut down, CSW can reveal.
The firm was part of Public Health England (the predecessor to the UK Health Security Agency) until 2015, …
-
Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston
16 Jun 2025 13:00 GMT
… ) is an advanced clinical stage drug development Company with a platform technology that …